Cognitive dysfunction with aging and the role of inflammation
- PMID: 23251749
- PMCID: PMC3513880
- DOI: 10.1177/2040622311399145
Cognitive dysfunction with aging and the role of inflammation
Abstract
As the average lifespan continues to climb because of advances in medical care, there is a greater need to understand the factors that contribute to quality of life in the elderly. The capacity to live independently is highly significant in this regard, but is compromised by cognitive dysfunction. Aging is associated with decreases in cognitive function, including impairments in episodic memory and executive functioning. The prefrontal cortex appears to be particularly vulnerable to the effects of advancing age. Although the mechanism of age-related cognitive decline is not yet known, age-related inflammatory changes are likely to play a role. New insights from preclinical and clinical research may give rise to novel therapeutics which may have efficacy in slowing or preventing cognitive decline with advancing age.
Keywords: aging; cognitive dysfunction; elderly; inflammation; quality of life.
Conflict of interest statement
The authors declare no conflict of interest in preparing this manuscript.
References
-
- Aalami O.O., Fang T.D., Song H.M., Nacamuli R.P. (2003) Physiological features of aging persons. Arch Surg 138: 1068–1076 - PubMed
-
- Ackerman P.L., Rolfhus E.L. (1999) The locus of adult intelligence: Knowledge, abilities, and nonability traits. Psychol Aging 14: 314–330 - PubMed
-
- Adair J.C., Knoefel J.E., Morgan N. (2001) Controlled trial of N-acetylcysteine for patients with probable Alzheimer's disease. Neurology 57: 1515–1517 - PubMed
-
- Aisen P.S., Davis K.L., Berg J.D., Schafer K., Campbell K., Thomas R.G., et al. (2000) A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study. Neurology 54: 588–593 - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
